Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lum

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Science Advances|February 1, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancerMarisa K Kilgour, Sarah MacPherson, Lauren G Zacharias, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2025
Retreatment of Hepatitis C Virus Among People Who Inject DrugsAurielle M Thomas, Alain H Litwin, Judith I Tsui, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Science (New York, N.Y.)|July 28, 2018
LKB1 deficiency in T cells promotes the development of gastrointestinal polyposisM C Poffenberger, A Metcalfe-Roach, E Aguilar, et al.
The New England Journal of Medicine|February 10, 2021
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV InfectionKimberly Page, Michael T Melia, Rebecca T Veenhuis, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2022
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trialAlain H Litwin, Paula J Lum, Lynn E Taylor, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Science Advances|February 1, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancerMarisa K Kilgour, Sarah MacPherson, Lauren G Zacharias, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2025
Retreatment of Hepatitis C Virus Among People Who Inject DrugsAurielle M Thomas, Alain H Litwin, Judith I Tsui, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Science (New York, N.Y.)|July 28, 2018
LKB1 deficiency in T cells promotes the development of gastrointestinal polyposisM C Poffenberger, A Metcalfe-Roach, E Aguilar, et al.
The New England Journal of Medicine|February 10, 2021
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV InfectionKimberly Page, Michael T Melia, Rebecca T Veenhuis, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2022
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trialAlain H Litwin, Paula J Lum, Lynn E Taylor, et al.
Pageof 26